Moleculera Biosciences

Moleculera Biosciences offers advanced testing services in a fully-accredited CLIA/COLA clinical laboratory specializing in autoimmune neurobiology. As pioneers focusing on neuropsychiatric disorders caused by molecular mimicry, we offer the Autoimmune Brain PanelTM, an aid to a physicians diagnosis of autoimmune-based neuropsychiatric disorders. The Autoimmune Brain PanelTM helps identify whether an individuals neurologic/psychiatric symptoms, such as obsessive compulsive behaviors, tics, anxiety, attention deficit hyperactivity disorder, and sometimes behaviors associated with Autism Spectrum Disorders, could be caused by a treatable autoimmune condition triggered by common infections

Immunology,lyme disease,autoimmune encephalopathy,pandas/pans,and neuropsychiatric illness

Moleculera biosciences operates in the Biotechnology industry.

Moleculera biosciences's revenue is 11m - 100m

Moleculera biosciences has 11 - 50 employees.